(19)
(11) EP 2 459 591 A1

(12)

(43) Date of publication:
06.06.2012 Bulletin 2012/23

(21) Application number: 10740103.6

(22) Date of filing: 30.07.2010
(51) International Patent Classification (IPC): 
C07K 16/18(2006.01)
A61K 39/395(2006.01)
G01N 33/50(2006.01)
C07K 16/22(2006.01)
C07K 16/24(2006.01)
A61P 35/04(2006.01)
G01N 33/574(2006.01)
C07K 16/28(2006.01)
(86) International application number:
PCT/US2010/043872
(87) International publication number:
WO 2011/014750 (03.02.2011 Gazette 2011/05)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(30) Priority: 31.07.2009 US 230571 P
02.06.2010 US 350558 P

(71) Applicant: Genentech, Inc.
South San Francisco, CA 94080 (US)

(72) Inventors:
  • FERRARA, Napoleone
    San Francisco California 94109 (US)
  • KOWANETZ, Marcin Leszek
    San Francisco California 94116 (US)

(74) Representative: Brodbeck, Michel 
F. Hoffmann-La Roche AG Patent Department CLP Grenzacherstrasse 124
4070 Basel
4070 Basel (CH)

   


(54) INHIBITION OF TUMOR METASTASIS USING BV8- OR G-CSF-ANTAGONISTS